IRIS
BERGAMINI, ALICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.065
NA - Nord America 3.343
AS - Asia 2.785
SA - Sud America 509
Continente sconosciuto - Info sul continente non disponibili 269
AF - Africa 43
OC - Oceania 13
AN - Antartide 1
Totale 12.028
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.134
RO - Romania 1.750
RU - Federazione Russa 1.700
SG - Singapore 943
CN - Cina 866
IT - Italia 776
BR - Brasile 417
HK - Hong Kong 257
VN - Vietnam 245
SE - Svezia 234
BD - Bangladesh 182
FR - Francia 124
DE - Germania 118
GB - Regno Unito 105
CA - Canada 98
IN - India 81
NL - Olanda 59
FI - Finlandia 50
MX - Messico 43
AR - Argentina 41
ES - Italia 38
JP - Giappone 35
PL - Polonia 32
TR - Turchia 31
ID - Indonesia 25
AT - Austria 20
ZA - Sudafrica 20
CR - Costa Rica 19
IE - Irlanda 18
IQ - Iraq 15
PK - Pakistan 15
CO - Colombia 13
MY - Malesia 13
JM - Giamaica 11
LT - Lituania 11
EC - Ecuador 10
BE - Belgio 9
VE - Venezuela 8
AU - Australia 7
JO - Giordania 7
MA - Marocco 7
NI - Nicaragua 7
PH - Filippine 7
UZ - Uzbekistan 7
CL - Cile 6
IL - Israele 6
PE - Perù 6
QA - Qatar 6
SA - Arabia Saudita 6
TT - Trinidad e Tobago 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
KR - Corea 5
NP - Nepal 5
TN - Tunisia 5
EG - Egitto 4
GT - Guatemala 4
HN - Honduras 4
NZ - Nuova Zelanda 4
UY - Uruguay 4
BB - Barbados 3
CH - Svizzera 3
IR - Iran 3
KZ - Kazakistan 3
PY - Paraguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GP - Guadalupe 2
GR - Grecia 2
KW - Kuwait 2
KY - Cayman, isole 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
HR - Croazia 1
HT - Haiti 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
SC - Seychelles 1
Totale 11.755
Salva come PNG Salva come JPEG
Città #
Singapore 469
Ashburn 460
Dallas 421
San Jose 385
Moscow 357
Hong Kong 255
Milan 217
Beijing 159
New York 153
Shanghai 141
Council Bluffs 130
Los Angeles 96
Hefei 94
Ho Chi Minh City 91
Lauterbourg 84
Santa Clara 67
Hanoi 62
Phoenix 58
Rome 52
Lawrence 47
Munich 46
Princeton 46
São Paulo 44
Boardman 42
Orem 40
Chennai 29
Denver 29
Warsaw 28
Tokyo 27
Turku 26
Bergamo 25
Vaprio d'Adda 25
Boston 24
Brooklyn 24
Nuremberg 24
Houston 23
Montreal 23
London 22
Atlanta 21
The Dalles 21
Manchester 20
Mexico City 20
Toronto 20
Amsterdam 19
Brescia 19
Chicago 18
Dublin 18
Florence 18
Haiphong 17
Helsinki 17
Naples 17
Seattle 17
Frankfurt am Main 16
Poplar 16
Stockholm 16
Columbus 15
Johannesburg 15
Buffalo 14
Omaha 14
Rio de Janeiro 14
Miano 13
San José 13
St Petersburg 13
Turin 12
Rho 11
San Francisco 11
Bari 10
Belo Horizonte 10
Cesano Boscone 10
Cleveland 10
Guangzhou 10
Mumbai 10
Pune 10
Shenzhen 10
Tianjin 10
Ankara 9
Charlotte 9
Gatchina 9
Istanbul 9
Kuala Lumpur 9
Philadelphia 9
Querétaro 9
Valencia 9
New Delhi 8
Paris 8
Vienna 8
Bologna 7
Brasília 7
Brussels 7
Kingston 7
Lappeenranta 7
Managua 7
Tashkent 7
Washington 7
Xi'an 7
Biên Hòa 6
Campinas 6
Cincinnati 6
Da Nang 6
Doha 6
Totale 5.079
Salva come PNG Salva come JPEG
Nome #
Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes 418
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 395
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 379
Do stage and grade of malignancy impact fertility preservation in breast cancer patients? 376
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin 360
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial 344
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 286
Additional value of uterine artery Doppler pulsatility index for ultrasound diagnosis of placental site trophoblastic tumor: prospective cohort study 267
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease 244
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 239
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 211
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 196
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 159
Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes 156
Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can! 151
[Anti-angiogenic drugs and hypertension: from multidisciplinary collaboration to greater care] 145
Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN) 142
A Pictorial Ultrasound Essay of Gestational Trophoblastic Disease 140
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 139
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 138
A prospective, observational study of chemotherapy-induced ovarian damage on follicular reserve and maturation 137
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 134
Dermatofibrosarcoma Protuberans of the Vulva: A Review of the MITO Rare Cancer Group 134
A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. 134
A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach 134
Ovarian failure risk in post-pubertal patients with cancer: a prognostic model 127
Chemotherapy-induced nausea in a sample of gynaecological cancer patients: assessment issues and personal risk factors evaluation 126
Chemotherapy-Induced Nausea and Vomiting in Women With Gynecological Cancer: A Preliminary Single-Center Study Investigating Medical and Psychosocial Risk Factors 125
Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison 124
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 119
Psychological factors influencing emotional reactions to gestational trophoblastic disease: The role of coping mechanisms and illness perception 119
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 118
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 115
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 114
What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome 114
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 113
Inhibition of Phosphodiesterase 4 Enhances Clitoral and Vaginal Blood Flow Responses to Dorsal Clitoral Nerve Stimulation or PGE1 in Anesthetized Female Rats 110
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 108
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer 106
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 105
Psychological Aspects Associated With Fertility Preservation in Oncology: An Exploratory Study 105
Contrast-enhanced ultrasound for ovary assessment in a murine model: preliminary findings on the protective role of a gonadotropin-releasing hormone analogue from chemotherapy-induced ovarian damage 102
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 101
Psychological aspects and fertility issues of GTD 101
Factors Associated With a High Motivation to Undergo Fertility Preservation in Female Cancer Patients 101
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 98
Socio-demographic and psychological factors associated with quality of life of women undergoing chemotherapy treatment for gynecological cancer 97
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 96
Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26) 95
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study 93
Transvaginal ultrasound in evaluation and follow-up of ovarian granulosa cell tumors 90
Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs 89
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 89
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 87
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 86
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 86
Tumori del trofoblasto di origine gestazionale: impatto psicologico e ruolo dei meccanismi di difesa nel percorso di malattia 86
Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis 86
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways 85
Carboplatin Use in Pregnancy for Stage IB3 Cervical Cancer: Case Report and Review of the Literature 84
Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study 84
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 83
Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence 82
Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery 82
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 81
Quality of life and chemotherapy: Predictive factors in a sample of gynaecological cancer patients 79
Fertility sparing surgery in epithelial ovarian cancer in Italy: perceptions, practice, and main issues 78
Gestational Trophoblastic Disease: the effect of mental representations on anxiety, depression, and infertility-related stress 77
Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study 77
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 76
Perioperative Betamethasone Treatment Reduces Signs of Bladder Dysfunction in a Rat Model for Neurapraxia in Female Urogenital Surgery 74
Hydatidiform mole: age-related clinical presentation and high rate of severe complications in older women 73
Role of Surgery in the Management of Hydatidiform Mole in Elderly Patients: A Single-Center Clinical Experience 73
Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis 72
Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors 72
Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study 71
Correction to: A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach (CVIR Endovascular, (2018), 1, 1, (30), 10.1186/s42155-018-0039-8) 71
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 69
Illness Perception in Gestational Trophoblastic Disease Patients: How Mental Representations Affect Anxiety, Depression, and Infertility-Related Stress 69
Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience 68
Different Patterns of Disease Spread between Advanced-Stage Type i and II Epithelial Ovarian Cancer 68
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 67
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 67
Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time? 67
Neoadjuvant chemotherapy in high-risk ovarian cancer patients: Role of age 67
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study 64
Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy. 63
Ovarian endometrioma: what the patient needs 61
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 60
Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition? 58
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors 57
Endometriosis-associated tumor at the inguinal site: report of a case diagnosed during pregnancy and literature review 57
Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: Retrospective analysis from the MITO-9 group 57
Small Cell Carcinoma of the Ovary: Report of Three Cases of a Poor Prognosis Disease 56
Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?". 56
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas. 54
Pelvic nerve injury negatively impacts female genital blood flow and induces vaginal fibrosis-implications for human nerve-sparing radical hysterectomy 53
Management of recurrent ovarian cancer: When platinum-based regimens are not a therapeutic option 53
Fertility preservation in women with cervical cancer 53
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 43
Totale 11.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202236 0 0 0 7 0 1 7 7 3 4 7 0
2022/2023622 107 78 25 10 8 42 185 58 48 16 39 6
2023/2024500 17 23 62 54 57 89 11 59 10 18 26 74
2024/20253.377 141 35 64 51 89 130 1.955 162 259 158 139 194
2025/20266.112 455 335 511 764 520 191 541 440 1.466 308 258 323
2026/20271.324 176 328 329 491 0 0 0 0 0 0 0 0
Totale 12.028